This business information is not released now.


Back
This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.


BONAC CORPORATION
【Field/Business】
Pharmaceutical/Drug Discovery
Drug discovery support/Contract service
Others
last update:2013/1/27
Profile

Delegates :
Hirotake Hayashi


Incorporated :
February  1 , 2010

Paid in Capital :
9 Million yen  

Employees :
13 人

Address :
Fukuoka BIO Factory 4-1488 Aikawa, Kurume FUKUOKA
〒8390861

TEL/FAX :
+81-942-32-6700 / +81-942-32-4600

URL:
http://www.bonac.com/

Attachment :

Mission/Background :
"BONAC" is derived from the initials of "Bridge Of Nucleic Acids Chemistry". The role of "BONAC" shall be a bridge for connecting technologies of nucleic acids chemistry and drug discovery through our technologies. "BONAC" is founded in Kurume City, Fukuoka Prefecture in February 2010, we have concentrated the research and development of nucleic acids chemistry and the manufacture of oligo nucleic acid.
In April 2012, we have launched two patents for the single-stranded RNA interference method, which are the cores of our business strategy.
Through two patents, we could overcome any technical issues on such as innate immunity and transportation of nucleic acid which nobody could resolve with traditional nucleic acid drugs.

Technology & Business
"BONAC nucleic acid", our core technology is long chain of single-stranded RNA, not traditional double-stranded RNA. It is possible to synthesize single-stranded RNA oligo with increasing five times the yield compared with traditional way to synthesize double-stranded RNA.
Furthermore, "BONAC Nucleic acid" shows high efficacy to the targeted diseases as it is increasing the level of resistance to degradation by digestive enzymes. Additionally, we have already confirmed that "BONAC Nucleic acid" prevents from inducting side effects by Toll like Receptor, also has the structure which being resistant to natural immunity.
Now, we are concentrating to expand our business based on our new technology, "BONAC nucleic acid" through joint research and development, searching the new seeds on developing new drugs and licensing business.
Products & Service
Products & Service Name
Stage
Outline
Milestone
Licensing business for basic patent.
Others
We offer the right of the use of the patent technologies we have.
Our aim is to collaborate with pharmatheuticals through our technologies.
COM business with reagents.
Discovery
We provide reagents for research (siRNA, miRNA).
Our aim is rising our business.
Joint development on drugs.
Preclinical
We will develop new drugs through collaboration with pharmaceuticals based on our patent technologies.
Our aim is to collaborate with pharmatheuticals through our technologies.








Highlights
1.Approval of patents
April 2012, two patents for the single-stranded RNA interference method were approved.

2.The start of the course donated from BONAC
September 2012, the course in Tokyo Medical University donated from BONAC was started. Many of professors or researchers from academia join this course.

3.Establishment of bio research center
2013, we will establish bio reaserch center in Uruma City, Okinawa Prefecture to realize nucleic acid drug discovery.
Hot news
We are preparing to establish bio reaserch center in Uruma City, Okinawa Prefecture.
Alliance strategy
We're looking for the oppotunity to collaborete with reliable partners who are interested in our technologies. Also looking for the oppotunity to collaborate with ones who are interested in joint research toward to nucleic acid drug discovery.

 
This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.